Insight
Insight
The European hemp and medical cannabis industries are rapidly evolving with Denmark establishing itself as the centre of this new and dynamic sector.
When
QNTM Labs (QNTM) is leading the development of testing and analysis standards for this burgeoning sector, helping to create new analytical methods that meet the needs of the industry in Denmark, Europe, and across the globe.
“We are pushing the cannabis industry to take a high standard pharmaceutical approach and challenging how the lab industry works in the process, as traditional lab facilities struggle to deliver medical cannabis testing at EU-GMP standards. QNTM Labs is solving a global problem for the cannabis industry that needs access to high standard, robust, and reliable scientific analysis.”Justin Ihnken and Connor Murphy
QNTM Labs Co-founders
As the need for advanced studies and laboratory investigation increases, QNTM Lab’s sophisticated approach to developing the hemp and medical cannabis industry continues to draw attention from innovative partners and strategic alliances globally.
Specifically, that of CBF Science Technologies (CBF Sci-Tech), a biotech player focused on advancing industrial hemp development and technological applications throughout Asia.
QNTM Labs has recently finalised a strategic partnership and investment contribution from CBF Sci-Tech, as they envision capabilities according to Danish standards, to be scaled up and implemented in international markets as the growth of the industrial hemp and medical cannabis sectors continue to develop.
"Denmark is a life sciences country that sets high standards. We compete on quality, innovation, trust, and long-term planning. Our system has created global pharma and biotech champions, that are among the most trusted and innovative in the world. This is the model upon which our hemp and medical cannabis are developing. It is fantastic to see the Danish model emerging as the global leader and to see partners across Europe, North America, and now Asia collaborate with Danish stakeholders to drive the industry forward.”Jeppe Solmer
Director, Invest in Denmark, Beijing
Similarly, to those within the EU, Chinese cannabis and hemp industry stakeholders must also prove quality and production standards in line with that of other international cannabis markets. These products will require the highest level of testing and certification to be recognised and accepted by international partners.
The approach taken by both QNTM and CBF Sci-Tech collectively unifies the extensive demand for redefining laboratory excellence in cannabis pharmaceuticals to fuel expansion in new markets across the world.
“The investment in QNTM Labs is a testimony to the two young founders’ drive and ability to analyse and identify a global industry problem and transform an idea to actual results. Without any prior experience from the industry, they have successfully managed to establish strong partnerships with a diverse stakeholder group, and they are now delivering high standard pharmaceutical analysis to the medical cannabis industry.”Christian Carlsen
Chairman of the Board at QNTM Labs
Denmark continues to emerge as the leading centre for the development of hemp for industrial uses with applications in medical cannabis that complements its position as a true Life Sciences nation. The global reach that is created in Denmark’s medical cannabis and hemp ecosystem is one that will continue to provide insight for QNTM as well as other developing markets across the globe.
"CBF Science Technologies has found that the analytical laboratory is the core link connecting upstream and downstream stakeholders, policymakers, and industry regulators. QNTM Labs has shown they are committed to the implementation of testing and research with the highest quality standards. Combined with our [CBF Science Technologies] development strategy, we will strive to become a recognized platform to support the common development and progression of the cannabinoid industry, globally."Mr. G. Peng
CEO of CBF Sci Tech
The dynamic ecosystem in Denmark is being further reinforced by active participation of Invest in Odense and its partners to foster a competitive environment with such activities as the Cannabis Investor Summit and funding from the Danish Board of Business Development, which finances regional activities in the medical cannabis sector.
The Danish medical cannabis industry builds on large international investments and visionary global collaborations. I am very pleased that yet another international investment into the emerging ecosystem has been made – it is simply fantastic! The City of Odense perceives QNTM Labs’ choice of Odense as a base for its operations as strong recognition of our persistent work in supporting the industry and provides fuel for continuing our strategic objective of leadership within the medical cannabis industry, in close collaboration with Invest in Denmark.
Peter Rahbæk Juel
Mayor of Odense, Denmark
Please don't hesitate to contact us.
Title: Special Advisor – Life Science
Area: Odense
Email: [email protected]
Phone: +45 6197 9141
